Hatch-Waxman and BPCIA Developments in June 2018

Published date09 July 2018
Law FirmMorrison & Foerster LLP
AuthorDavid Manspeizer
Subject MatterSEC,ANDA,Medical Devices,Life Sciences,SCOTUS,Hatch-Waxman,Patent Trial and Appeal Board,BPCIA,Teva Pharmaceuticals,Antitrust Division,Pharmaceutical Industry,Constitutional Challenges,Lucia v SEC

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT